NCT04226963View on ClinicalTrials.gov

A Naturalistic Study of Ketamine for Treatment Resistant Mood Disorders

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

December 4, 2019

Primary Completion Date

July 4, 2022

Study Completion Date

July 4, 2022

Conditions
Treatment Resistant DepressionBipolar DepressionKetamineMajor Depressive Disorder
Interventions
DRUG

Ketamine

Ketamine will be infused (slow IV infusions of ketamine (0.5 mg/kg) over 40 minutes) twice weekly over a period of 4 weeks) Ketamine will be given in intranasal spray twice weekly over a period of 4 weeks Ketamine will be given orally (solution 2.0mg/kg, 2.5mg/kg) twice weekly over a period of 4 weeks.

Trial Locations (1)

80-952

Department of Psychiatry, Medical University of Gdańsk, Gdansk

All Listed Sponsors
lead

Medical University of Gdansk

OTHER

NCT04226963 - A Naturalistic Study of Ketamine for Treatment Resistant Mood Disorders | Biotech Hunter | Biotech Hunter